African Union Development Agency (AUDA-NEPAD) COVID19 Webinar Series on galvanising African industrial capacity to supply pharmaceuticals and medical products

Topic: Opportunities for improved market access for local pharmaceutical manufacturers in Africa – Implications of the African Continental Free Trade Agreement (AfCFTA)

16th July 2020

3pm S.A.S.T / 1pm GMT


Assembly Decision {Assembly/AU/Dec.55(IV)} taken during the Abuja Summit in January 2005 requested the AU Commission to develop a Pharmaceutical Manufacturing Plan for Africa (PMPA) within the framework of the then NEPAD.

In 2012 the 19th African Union Assembly Decision {Assembly AU/Dec.442(XIX)} on AU endorsed the PMPA Business plan which provides a package of technical and policy solutions to the challenges hampering Africa’s progress to achieve the PMPA’s objective of creating a viable pharmaceutical industry that can provide in a sustainable manner the much needed essential medical products to improve public health outcomes while creating jobs, boosting research and development across the pharmaceutical manufacturing value chain and enhancing the industrial base of the continent.

Partnerships, Collaborations and Fostering Business Linkages, as a pillar advocated for in the PMPA and its associated business plan for operationalising the Pharmaceutical Manufacturing Plan for Africa. The implementation of PMPA has received a boost with the launch and subsequent signing of the African Continental Free Trade Agreement (AfCFTA).

In order for Africa to attain self-sufficiency in pharmaceutical production, improved health outcomes and increased access to essential medicines, National Medicines Regulatory Authority (NMRA)s or equivalents have a critical role to play. Africa’s NMRAs must ensure that medicines on the market are quality assured, safe and efficacious.

A unified African market not only ensure uniformity along quality control, it is also a critical determinant of increased access to investments and better health outcomes for the people. A unified African market ensures collaboration along trade lines, increases market access and subsequently offers economies of scale and scope.

These benefits become more critical in the wake of the Covid19 pandemic making it necessary for Africa, more than ever, to look inward for solutions to curb the negative effect of the pandemic and the dependence on aid from other continents.

It is against this background that AUDA-NEPAD is organising a series of webinars, which was launched on 13 th April 2020, and its aimed at galvanising African industrial capacity to produce the much-needed pharmaceuticals and medical supplies to respond to Covid19 and future pandemics.

Speakers and Panelists

Keynote Speakers

Mr. Wamkele Mene

Mr. Wamkele Mene,

The Secretary General of the AfCFTA

Dr David Luke

Dr. David Luke

UNECA, Coordinator of the African Trade Policy Centre at the UN Economic Commission for Africa



Omilola Babatunde Olumide

Manager, Public Health, Security and Nutrition Division AfDB


Nazeem Mohamed


Prudence Sebahizi

Prudence Sebahizi

Chief Technical Advisor on the African Continental Free Trade AUC

Facilitator & Closing Remarks

Dr. Janet Byaruhanga,

Dr. Janet Byaruhanga

Senior Programme Officer, Public Health, AUDA-NEPAD


Olakunle Olaniyi-Edwards

Executive Director, DFS-Africa


AUDA-NEPAD, FAPMA and its regional TRADE associations, SAGMA, WAPMA, FEAPM, AfDB, Afrexim Bank, UNECA, USP, DFS Africa. These will be joined by a range of other invitees from the UN, NGOs, Academia, development partners and the public.

Speaker Presentation Link Webinar Report Webinar Video Recording
Dr. David Luke - UNECA, Coordinator of the African Trade Policy Centre at the UN Economic Commission for Africa
Mr. Silver Ojakol - Chief of Staff (On behalf of SG) AfCFTA Secretariat